IBD Research Unit: PhD dissertations

  • Lien Van den Bossche (2017): Bile acids as novel therapeutic agents for inflammatory bowel disease (promotor: Prof. Debby Laukens, copromotor: Prof. Martine De Vos) link
  • Sophie Van Welden (2017): Prolyl hydroxylase domain-containing protein 1 as potential therapeutic target for inflammatory bowel disease  (promotor: Prof. Debby Laukens, copromotor: Dr. Pieter Hindryckx) link
  • Sarah Devriese (2017):  Treatment strategies for intestinal epithelial barrier dysfunction in inflammatory bowel disease (promotor: Prof. Debby Laukens, copromotor: Prof. Martine De Vos) link
  • Lindsey Devisscher (2014): Metallothioneins as modulators of intestinal inflammation and potential therapeutic targets for inflammatory bowel diseases (promotor: Prof. Martine De Vos, copromotor: Prof. Debby Laukens) link
  • Sara Bogaert (2012): Exploring expression patterns of genes involved in susceptibility pathways of inflammatory bowel disease (promotor: Prof. Martine De Vos, copromotor: Prof. Debby Laukens) link
  • Pieter Hindryckx (2011): Mucosal hypoxia and angiogenesis as potential therapeutic targets for inflammatory bowel disease (promotor: Prof. Martine De Vos, copromotor: Prof. Dirk Elewaut) link
  • Anouk Waeytens (2009): The damaged mucosal barrier in intestinal inflammation (promotor: Prof. Claude Cuvelier, copromotor: Prof. Martine De Vos) link
  • Harald Peeters (2006): The role of genetic alterations in the gut-joint axis of Crohn's disease and Spondyloarthropathies (promotor: Prof. Martine De Vos, copromotor: Prof. Filip De Keyser)
  • Debby Laukens (2006): Transcriptome profiling and genetic analysis to identify and characterize susceptibility genes for Crohn’s disease (promotor: Prof. Erik Remaut, copromotor: dr. Pieter Rottiers) link